FGEN vs PH · rev $29.6M vs P/E 28, rev $19.85B
FibroGen Inc (FGEN) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
FGEN currently screens at market cap $39.3M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the FGEN and PH stock pages for the full models.
Not investment advice.